Engineered CAR T cells show promise against solid tumors
Chimeric antigen receptor (CAR) T cell therapy, which uses a patient’s own immune cells to fight cancer, has…
Genetic risk scores fail to predict survival after diagnosis
New research across seven global biobanks shows that the DNA driving disease onset does not determine survival; instead,…
UCLA presents advances in radiation therapy at ASTRO 2025
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results…
Common bladder infection may signal urogenital cancer risk
A bout of the common bladder infection, cystitis, may signal the presence of urogenital cancers-which affect parts of…
Colorectal cancer identified by its unique microbial fingerprint
Colorectal cancer is unique in having its own microbial ‘fingerprint’ – according to new research from the University…
SOX2 drives progression and therapy resistance in advanced prostate cancer
Prostate cancer remains a global health challenge, ranking as the second most common malignancy among men. While early-stage…
New ‘dual-mode’ tracer agent enhances precision in prostate cancer procedures
A preclinical evaluation of a new ‘dual-mode’ tracer agent shows promise in not only helping surgeons image and…